文献速递瓣膜病与结构性心脏病

18F-FDG PET/CT对感染性心内膜炎的预后价值

Prognostic Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Infective Endocarditis.
PubMed 文献 · J Am Coll Cardiol · 2019-01-01

该前瞻性研究纳入173例明确左侧感染性心内膜炎患者(109例人工瓣膜心内膜炎、64例自体瓣膜心内膜炎),均行18F-FDG PET/CT并随访1年。结果显示,在人工瓣膜心内膜炎中,PET/CT阳性与主要心脏事件风险升高相关,且中度至 intense 瓣膜摄取与不良结局及新发栓塞事件相关;在自体瓣膜心内膜炎中,PET/CT与主要终点无显著关联。

要点

  • 在人工瓣膜心内膜炎中,18F-FDG PET/CT阳性与主要心脏事件风险升高独立相关。
  • 中度至 intense 瓣膜摄取与人工瓣膜心内膜炎不良结局及新发栓塞事件相关。
  • 在自体瓣膜心内膜炎中,18F-FDG PET/CT未显示与主要终点相关。

核心结论

  • 18F-FDG PET/CT除诊断性能良好外,可预测人工瓣膜心内膜炎的主要心脏事件及感染性心内膜炎后1年内的新发栓塞事件。

研究设计与样本

  • 前瞻性纳入173例明确左侧感染性心内膜炎患者,其中人工瓣膜心内膜炎109例、自体瓣膜心内膜炎64例,均行18F-FDG PET/CT并随访1年。

主要发现

  • 18F-FDG PET/CT在100例(58%)患者中为阳性,人工瓣膜心内膜炎组83%(90/109),自体瓣膜心内膜炎组16%(10/64)。
  • 平均随访225天(四分位距199至251天)期间,94例(54%)发生主要终点,人工瓣膜心内膜炎组63例(58%),自体瓣膜心内膜炎组31例(48%)。
  • 在人工瓣膜心内膜炎组,PET/CT阳性与主要终点发生率更高显著相关(HR 2.7;95%CI 1.1-6.7;p=0.04)。
  • 中度至 intense 18F-FDG瓣膜摄取与更差结局相关(HR 2.3;95%CI 1.3-4.5;p=0.03),并与人工瓣膜心内膜炎新发栓塞事件相关(HR 7.5;95%CI 1.24-45.2;p=0.03)及自体瓣膜心内膜炎新发栓塞事件相关(HR 8.8;95%CI 1.1-69.5;p=0.02)。
  • 在自体瓣膜心内膜炎组,18F-FDG PET/CT与主要终点的发生无关。

临床怎么用

  • 对于人工瓣膜心内膜炎患者,18F-FDG PET/CT阳性及中度至 intense 瓣膜摄取可提示主要心脏事件和新发栓塞事件风险升高,有助于风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) is commonly used for the diagnosis of infective endocarditis (IE), but its prognostic value remains unknown. OBJECTIVES: This study sought to assess the prognostic value of 18F-FDG PET/CT in prosthetic valve endocarditis (PVE) and native valve endocarditis (NVE). METHODS: This study prospectively included 173 consecutive patients (109 PVE and 64 NVE) with definite left-sided IE who had an 18F-FDG PET/CT and were followed-up for 1 year. The primary endpoint was a composite of major cardiac events: death, recurrence of IE, acute cardiac failure, nonscheduled hospitalization for cardiovascular indication, and new embolic event. RESULTS: 18F-FDG PET/CT was positive in 100 (58%) patients, 83% (n = 90 of 109) in the PVE, and 16% (n = 10 of 64) in the NVE group. At a mean follow-up of 225 days (interquartile range: 199 to 251 days), the primary endpoint occurred in 94 (54%) patients: 63 (58%) in the PVE group and 31 (48%) in the NVE group. In the PVE group, positive 18F-FDG PET/CT was significantly associated with a higher rate of primary endpoint (hazard ratio [HR]: 2.7; 95% confidence interval [CI]: 1.1 to 6.7; p = 0.04). Moderate to intense 18F-FDG valvular uptake was also associated with worse outcome (HR: 2.3; 95% CI: 1.3 to 4.5; p = 0.03) and to new embolic events in PVE (HR: 7.5; 95% CI: 1.24 to 45.2; p = 0.03) and in NVE (HR: 8.8; 95% CI: 1.1 to 69.5; p = 0.02). In the NVE group, 18F-FDG PET/CT was not associated with occurrence of the primary endpoint CONCLUSIONS: In addition to its good diagnostic performance, 18F-FDG PET/CT is predictive of major cardiac events in PVE and new embolic events within the first year following IE.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. San S, Ravis E, Tessonier L, et al. Prognostic Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Infective Endocarditis. J Am Coll Cardiol. 2019. PMID: 31439211. doi:10.1016/j.jacc.2019.06.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。